An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
Clinical trial NCT03361956 · COMPLETED
Trial details
- NCT number
- NCT03361956
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-13
- Primary completion
- 2019-09-05
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.